The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study

Glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐2 (GLP‐2) are gut hormones secreted postprandially. In healthy humans, both hormones decrease bone resorption accompanied by a rapid reduction in parathyroid hormone (PTH). The aim of this study was to investigate whether t...

Descripción completa

Detalles Bibliográficos
Autores principales: Skov‐Jeppesen, Kirsa, Hepp, Nicola, Oeke, Jannika, Hansen, Morten Steen, Jafari, Abbas, Svane, Maria Saur, Balenga, Nariman, Olson, John A, Frost, Morten, Kassem, Moustapha, Madsbad, Sten, Beck Jensen, Jens‐Erik, Holst, Jens Juul, Rosenkilde, Mette Marie, Hartmann, Bolette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338760/
https://www.ncbi.nlm.nih.gov/pubmed/33852173
http://dx.doi.org/10.1002/jbmr.4308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338760/
https://www.ncbi.nlm.nih.gov/pubmed/33852173
http://dx.doi.org/10.1002/jbmr.4308

Ejemplares similares